Michael Suranyi

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Geoffrey A. Block, Kévin Martin, Ángel Francisco et al. · New England Journal of Medicine · 2004 · 1.1K citations

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes

David W. Johnson, Fiona G. Brown, Margaret Clarke et al. · Journal of the American Society of Nephrology · 2012 · 198 citations · Full text

Elevated Levels of Tumor Necrosis Factor-α in the Nephrotic Syndrome in Humans

Michael Suranyi, Antonio Guasch, Bruce M. Hall et al. · American Journal of Kidney Diseases · 1993 · 167 citations

Glomerular Disease, Renal Pathology, Immunology +17

The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

David W. Johnson, F. G. Brown, Mary Clarke et al. · Nephrology Dialysis Transplantation · 2012 · 102 citations · Full text